Cerebrovascular Disease Profiles of Culturally and Linguistically Diverse Communities in South Western Sydney and New South Wales.

Humans New South Wales / epidemiology Australia / epidemiology Ischemic Attack, Transient / diagnosis Stroke / diagnosis Diabetes Mellitus, Type 2 Retrospective Studies Brain Ischemia Hypertension Obesity
Cardiovascular risk factors Culturally and linguistically diverse communities Stroke Transient ischaemic attack

Journal

Cerebrovascular diseases (Basel, Switzerland)
ISSN: 1421-9786
Titre abrégé: Cerebrovasc Dis
Pays: Switzerland
ID NLM: 9100851

Informations de publication

Date de publication:
2022
Historique:
received: 20 01 2022
accepted: 15 02 2022
pubmed: 14 5 2022
medline: 27 12 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

Culturally and linguistically diverse (CALD) communities are growing globally. Understanding patterns of cerebrovascular disease in CALD communities may improve health outcomes through culturally specific interventions. We compared rates of transient ischaemic attack (TIA)/stroke (ischaemic stroke, intracerebral haemorrhage) and stroke risk factor prevalence in overseas and Australian-born people in South Western Sydney (SWS) and New South Wales (NSW). This was a 10-year retrospective analysis (2011-2020) of SWS and NSW age-standardized rates per 100,000 person-years of TIA/stroke. Data were extracted from Health Information Exchange and Secure Analytics for Population Health Research and Intelligence systems. Rates of hypertension, type 2 diabetes mellitus (T2DM), atrial fibrillation (AF), smoking, and obesity were also calculated. The SWS and NSW age-standardized rate of TIA/stroke for people born in Australia was 100 per 100,000 person-years (100/100,000/year). In SWS, 56.6% of people were overseas-born compared to 29.8% for NSW. The age-standardized rate of TIA/stroke for Polynesian-born people was more than double that of Australian-born people (p < 0.001). Hypertension (33 [SWS] vs. 27/100,000/year [NSW]) and T2DM (36 [SWS] vs. 26/100,000/year [NSW]) were the most common risk factors with rates >50/100,000/year (hypertension) and >80/100,000/year (T2DM) for people born in Polynesia, Melanesia, and Central America. Rates of T2DM, AF, and obesity for Polynesian-born people were over threefold greater than people born in Australia. Greater rates of TIA/stroke were observed in specific CALD communities, with increased rates of cerebrovascular risk factors. Culturally specific, targeted interventions may bridge health inequalities in cerebrovascular disease.

Identifiants

DOI: 10.1159/000524242 PMID: 35551130
pubmed: 35551130
pii: 000524242
doi: 10.1159/000524242
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

744-754

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Dennis Cordato (D)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Christopher Blair (C)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia, christopher.blair@health.nsw.gov.au.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia, christopher.blair@health.nsw.gov.au.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia, christopher.blair@health.nsw.gov.au.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia, christopher.blair@health.nsw.gov.au.

Peter Thomas (P)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

Angela Firtko (A)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

Megan Miller (M)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Leon Stephen Edwards (LS)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

James Thomas (J)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Anna H Balabanski (AH)

Melbourne Brain Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Neuroscience, Monash University, Clayton, Victoria, Australia.
Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.

Angela Dos Santos (A)

South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Melbourne Brain Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Neuroscience, Monash University, Clayton, Victoria, Australia.
Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.

Longting Lin (L)

South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Suzanne Hodgkinson (S)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

Cecilia Cappelen-Smith (C)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

Roy G Beran (RG)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
School of Medicine, Griffith University, Broadbeach, Queensland, Australia.
Sechenov Moscow First State University, Moscow, Russian Federation.

Alan McDougall (A)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

Mark Parsons (M)

Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Stroke and Research Group, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Sydney Brain Centre, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Nouvelle-Galles du Sud › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Encéphalopathie ischémique › Accident ischémique transitoire › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Accident vasculaire cérébral › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète de type 2 › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Encéphalopathie ischémique › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Hypertension artérielle › Cerebrovascular Disease Profiles of Culturally...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Cerebrovascular Disease Profiles of Culturally...